JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J.-Y.
Right arrow Articles by Chen, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J.-Y.
Right arrow Articles by Chen, J.-C.
Related Collections
Right arrow Pain
Right arrow Pharmacology
Anesth Analg 2001;92:1563-1568
© 2001 International Anesthesia Research Society

PAIN MEDICINE

Modulations of Spinal Serotonin Activity Affect the Development of Morphine Tolerance

Jihn-Yih Li, MD, Chung-Hang Wong, MD, Eagle Y.-K. Huang, PhD*, Yen-Chien Lin, Yun-Long Chen, Peter P. C. Tan, MD, and Jin-Chung Chen, PhD

Department of Anesthesiology, Chang-Gung Memorial Hospital, and Department of Pharmacology, Chang-Gung University, Taiwan, ROC, and *Department of Pharmacology, National Defense Medical Center, Taiwan, ROC

Address correspondence and reprint requests to Dr. Jin-Chung Chen, Department of Pharmacology, Chang Gung University, 259 Wen-Hwa 1st Road, Tao-Yuan, Kwei-Shan, Taiwan, ROC. Address e-mail to Jinchen{at}mail.cgu.edu.tw

Abstract

To test whether modulations of spinal serotonin (5-HT) levels would affect the development of morphine tolerance, we treated rats with either intrathecal 5-HT or 5,7-dihydroxytryptamine (5,7-DHT; a 5-HT neurotoxin) in addition to systemic infusion with morphine (2 mg · kg-1 · h-1). Continuous infusion of 5-HT (10 µg · 6 µL-1 · h-1) into the lumbar subarachnoid space of rats for 9 h accelerated the development of morphine tolerance. The area under the curve for the tail-flick latency test was 454.1 ± 35.1 in the Sham Control group vs 327.6 ± 41.0 in the 5-HT-Infused group. µ-opioid receptor binding in the lumbar spinal cord showed a decrease in the Bmax (maximal binding -46.5%), but not the binding affinity (Kd), in 5-HT-infused rats. However, intrathecal injection of 5,7-DHT (50 µg), which resulted in a 48% reduction in 5-HT and 51% reduction in 5-hydroxyindoleacetic acid concentrations, led to an attenuation of morphine tolerance (the area under the curve was 613.0 ± 24.7 in the 5,7-DHT-Lesioned group). The binding study indicated that the affinity of lumbar µ-opioid receptors decreased 196% in 5-HT-depleted rats, whereas there was no effect on apparent binding. The infusion of 5-HT (10 µg · 6 µL-1 · h-1) was not analgesic and the 5,7-DHT-induced lesion did not affect acute morphine-induced analgesia. We conclude that activity of spinal 5-HT-containing neurons plays a crucial role during the development of morphine tolerance.

Implications: Spinal cord serotonin (5-HT) levels seem to be critical in the development of morphine tolerance. Reduction of 5-HT levels in the spinal cord prolonged the development of tolerance to morphine. Manipulation of 5-HT levels could be a valuable method for altering the efficacy of opioid analgesia, particularly during patient-controlled analgesia.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
Z.-Q. Zhao, Y.-J. Gao, Y.-G. Sun, C.-S. Zhao, R. W. Gereau IV, and Z.-F. Chen
Central serotonergic neurons are differentially required for opioid analgesia but not for morphine tolerance or morphine reward
PNAS, September 4, 2007; 104(36): 14519 - 14524.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
J. Streltzer and L. Johansen
Prescription Drug Dependence and Evolving Beliefs About Chronic Pain Management
Am J Psychiatry, April 1, 2006; 163(4): 594 - 598.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
M. Garnier, P. F. Zaratin, G. Ficalora, M. Valente, L. Fontanella, M.-H. Rhee, K. J. Blumer, and M. A. Scheideler
Up-Regulation of Regulator of G Protein Signaling 4 Expression in a Model of Neuropathic Pain and Insensitivity to Morphine
J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1299 - 1306.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.